CN117355310A - 核糖醇治疗 - Google Patents
核糖醇治疗 Download PDFInfo
- Publication number
- CN117355310A CN117355310A CN202180073484.0A CN202180073484A CN117355310A CN 117355310 A CN117355310 A CN 117355310A CN 202180073484 A CN202180073484 A CN 202180073484A CN 117355310 A CN117355310 A CN 117355310A
- Authority
- CN
- China
- Prior art keywords
- day
- ribitol
- dose
- comprises administering
- method comprises
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Organic Chemistry (AREA)
- Neurology (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physical Education & Sports Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Saccharide Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Molecular Biology (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063076761P | 2020-09-10 | 2020-09-10 | |
| US63/076,761 | 2020-09-10 | ||
| PCT/US2021/049677 WO2022056137A1 (en) | 2020-09-10 | 2021-09-09 | Ribitol treatment |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN117355310A true CN117355310A (zh) | 2024-01-05 |
Family
ID=80629815
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202180073484.0A Pending CN117355310A (zh) | 2020-09-10 | 2021-09-09 | 核糖醇治疗 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230364118A1 (https=) |
| EP (1) | EP4210708A4 (https=) |
| JP (1) | JP2023544249A (https=) |
| KR (1) | KR20230069941A (https=) |
| CN (1) | CN117355310A (https=) |
| AU (1) | AU2021338706A1 (https=) |
| CA (1) | CA3191582A1 (https=) |
| IL (1) | IL301088A (https=) |
| MX (1) | MX2023001881A (https=) |
| WO (1) | WO2022056137A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10434113B2 (en) | 2016-12-16 | 2019-10-08 | The Charlotte Mecklenburg Hospital Authority | Compositions and methods for treating muscular dystrophy and other disorders |
| AU2020283556A1 (en) | 2019-05-28 | 2022-01-06 | The Charlotte-Mecklenburg Hospital Authority D/B/A Atrium Health | Compositions and methods of making ribitol |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10245235B2 (en) * | 2016-12-16 | 2019-04-02 | The Charlotte-Mecklenburg Hospital Authority | Compositions and methods for treating muscular dystrophy and other disorders |
| US20200061092A1 (en) * | 2018-08-24 | 2020-02-27 | The Charlotte Mecklenburg Hospital Authority D/B/A Atrium Health | Methods and compositions for treating disorders associated with muscle weakness |
-
2021
- 2021-09-09 AU AU2021338706A patent/AU2021338706A1/en active Pending
- 2021-09-09 IL IL301088A patent/IL301088A/en unknown
- 2021-09-09 WO PCT/US2021/049677 patent/WO2022056137A1/en not_active Ceased
- 2021-09-09 MX MX2023001881A patent/MX2023001881A/es unknown
- 2021-09-09 CN CN202180073484.0A patent/CN117355310A/zh active Pending
- 2021-09-09 US US18/044,747 patent/US20230364118A1/en active Pending
- 2021-09-09 CA CA3191582A patent/CA3191582A1/en active Pending
- 2021-09-09 JP JP2023515723A patent/JP2023544249A/ja active Pending
- 2021-09-09 KR KR1020237010497A patent/KR20230069941A/ko active Pending
- 2021-09-09 EP EP21867600.5A patent/EP4210708A4/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CA3191582A1 (en) | 2022-03-17 |
| AU2021338706A1 (en) | 2023-05-25 |
| EP4210708A1 (en) | 2023-07-19 |
| EP4210708A4 (en) | 2024-10-23 |
| WO2022056137A1 (en) | 2022-03-17 |
| IL301088A (en) | 2023-05-01 |
| JP2023544249A (ja) | 2023-10-23 |
| MX2023001881A (es) | 2023-04-03 |
| US20230364118A1 (en) | 2023-11-16 |
| KR20230069941A (ko) | 2023-05-19 |
| WO2022056137A9 (en) | 2022-04-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12427161B2 (en) | Methods for treating and pharmaceutical compositions | |
| JP6612370B2 (ja) | ポンペ病の処置のための投与計画 | |
| JP6387010B2 (ja) | 血中グルコースレベルを制御することによる糖尿病及び関連容態の処置のための組成物、方法及び使用 | |
| CZ295567B6 (cs) | Tetrahydrolipstatin pro výrobu orálního farmaceutického prostředku pro ošetřování typu II diabetes mellitus | |
| WO2002028348A2 (en) | Compositions and methods for treatment of cystic fibrosis | |
| EP3065725A2 (en) | Use of cysteamine and derivatives thereof to treat mitochondrial diseases | |
| CN117355310A (zh) | 核糖醇治疗 | |
| TW201713324A (zh) | Ａｄｏ抗性半胱胺類似物及其用途 | |
| US20200061092A1 (en) | Methods and compositions for treating disorders associated with muscle weakness | |
| CN101677972A (zh) | 一种用于治疗神经变性疾病的奈拉美生的新组合物 | |
| WO2012154779A1 (en) | Combinations of oxybutynin and salivary stimulants for the treatment of overactive bladder | |
| US20180333399A1 (en) | Method of improving liver function | |
| WO2026013261A1 (en) | Nizubaglustat for use in the treatment of lysosomal storage disorders | |
| HK40058710A (en) | Dosing regimens for the treatment of pompe disease | |
| HK40112795A (en) | Dosing regimens for the treatment of pompe disease | |
| WO2025212841A1 (en) | Compositions and methods for treating diseases and disorders associated with muscle weakness | |
| KR20250113341A (ko) | 나트륨 포도당 운반체-2 저해제 및 안지오텐신 ⅱ 수용체 차단제를 함유하는 비만 예방 또는 치료용 약학적 조성물 | |
| US20260069545A1 (en) | Modified release formulations of ibudilast | |
| AU2013202988B2 (en) | Method of improving liver function | |
| WO2026037397A1 (zh) | Glp-1类似物的医药用途 | |
| JP2008273859A (ja) | 腎機能障害を持つ心不全患者を治療するためのコハク酸シベンゾリンを有効成分とする不整脈治療剤 | |
| AU2014346703A1 (en) | Use of cysteamine and derivatives thereof to treat mitochondrial diseases | |
| WO2012154778A1 (en) | Combinations of imidafenacin and salivary stimulants for the treatment of overactive bladder | |
| MX2012014757A (es) | Composicion farmaceutica de una meglitinida y una tiazolidinediona o sus sales farmaceuticamente aceptables y su uso. | |
| WO2012154775A1 (en) | Combinations of darifenacin and salivary stimulants for the treatment of overactive bladder |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |